Birk Harjus, Zygourakis Corinna C, Kliot Michel
School of Medicine, University of California, San Francisco, California, USA; Department of Neurological Surgery, University of California, San Francisco, CA, USA.
Department of Neurological Surgery, University of California, San Francisco, CA, USA.
Surg Neurol Int. 2016 Aug 26;7:80. doi: 10.4103/2152-7806.189299. eCollection 2016.
Peripheral nerve tumors such as neurofibromas and schwannomas have become increasingly identified secondary to improved imaging modalities including magnetic resonance neurogram and ultrasound. Given that a majority of these peripheral nerve tumors are benign lesions, it becomes important to determine appropriate management of such asymptomatic masses. We propose a normal cost-effective management paradigm for asymptomatic peripheral nerve neurofibromas and schwannomas that has been paired with economic analyses. Specifically, our management paradigm identifies patients who would benefit from surgery for asymptomatic peripheral nerve tumors, while providing cost-effective recommendations regarding clinical exams and serial imaging for such patients.
诸如神经纤维瘤和神经鞘瘤等周围神经肿瘤，由于包括磁共振神经造影和超声在内的成像方式的改进，其检出率越来越高。鉴于这些周围神经肿瘤大多数是良性病变，确定对此类无症状肿块的适当管理变得很重要。我们提出了一种针对无症状周围神经神经纤维瘤和神经鞘瘤的具有成本效益的正常管理模式，并结合了经济分析。具体而言，我们的管理模式确定了哪些患者将从无症状周围神经肿瘤的手术中获益，同时为这些患者提供有关临床检查和系列成像的具有成本效益的建议。
